Hormonal Health and Libido: Understanding the Connection
Sexual desire is a complex interplay of psychological, relational, and biological factors. Among the biological drivers, hormonal health plays a central role. Understanding which hormones influence li

In this article
Sexual desire is a complex interplay of psychological, relational, and biological factors. Among the biological drivers, hormonal health plays a central role. Understanding which hormones influence libido, and how, can help individuals and their clinicians identify potential contributors to changes in desire.
Key Hormones Involved in Libido
Testosterone

Testosterone is often called the primary hormone of desire. While it is present in much higher concentrations in men, it also plays a critical role in female sexual desire. Research published in the Archives of Sexual Behavior found that testosterone levels were positively associated with sexual desire in both men and women.
In men, testosterone acts directly on brain regions associated with sexual motivation. Low testosterone (hypogonadism) is one of the most well-documented biological causes of reduced libido in males.
In women, even small fluctuations in bioavailable testosterone can influence desire. Post-menopausal women and those who have undergone oophorectomy frequently experience reduced desire, partly attributable to declining androgen levels.
Estrogen
Estrogen, primarily estradiol, supports vaginal lubrication, tissue health, and blood flow to genital tissues. While estrogen's role in desire is more indirect than testosterone's, low estrogen levels, common during perimenopause, menopause, and postpartum periods, can cause physical discomfort during intimacy that secondarily reduces desire.
In men, estradiol plays a role in modulating libido as well. Research has shown that extremely low estradiol levels in men, such as those produced by aromatase inhibitors, can impair sexual function.
Progesterone
Progesterone's relationship to libido is nuanced. Elevated progesterone during the luteal phase of the menstrual cycle is associated with somewhat reduced sexual desire in some women. Synthetic progestins found in hormonal contraceptives can also impact desire, though responses vary significantly between individuals.
Thyroid Hormones
Both hypothyroidism and hyperthyroidism can disrupt sexual function. A review in Endocrine Reviews documented that thyroid dysfunction is associated with reduced desire, arousal difficulties, and orgasmic dysfunction in both sexes. Importantly, treatment of the underlying thyroid condition often restores sexual function.
Prolactin
Elevated prolactin levels (hyperprolactinemia) suppress gonadotropin-releasing hormone, which in turn reduces testosterone and estrogen production. This condition can result from pituitary adenomas, certain medications (particularly antipsychotics and some antidepressants), or hypothyroidism. It is a treatable cause of low libido in both men and women.
How Hormonal Imbalances Develop
Several common factors contribute to hormonal disruption:
- Aging, Natural decline in testosterone and estrogen production
- Chronic stress, Elevated cortisol suppresses gonadal hormone production via the hypothalamic-pituitary-adrenal axis
- Poor sleep, Disrupted circadian rhythms impair pulsatile hormone release
- Medications, Hormonal contraceptives, antidepressants, opioids, and corticosteroids can all affect sex hormones
- Body composition, Excess adipose tissue increases aromatase conversion and alters hormone ratios
- Nutritional deficiencies, Zinc, vitamin D, and magnesium deficiencies can impair hormone synthesis
Assessment and Evaluation
A comprehensive hormonal evaluation for libido concerns typically includes:
- Total and free testosterone
- Estradiol
- Sex hormone-binding globulin (SHBG)
- Thyroid panel (TSH, free T3, free T4)
- Prolactin
- DHEA-S
- Comprehensive metabolic panel
Evidence-Based Approaches
Depending on the underlying cause, interventions may include:
- Lifestyle optimization, Sleep, exercise, stress management, and nutrition
- Medication review, Identifying and adjusting medications that may be contributing to hormonal disruption
- Hormonal therapy, Testosterone replacement in confirmed hypogonadism, estrogen therapy for menopausal symptoms, or thyroid hormone optimization
- Treating underlying conditions, Prolactinoma management, correction of thyroid dysfunction
Practical Takeaways
- Reduced libido frequently has a hormonal component that is identifiable through bloodwork
- Multiple hormones work in concert; addressing one axis may not resolve symptoms if others are also disrupted
- Both men and women benefit from comprehensive hormonal assessment rather than single-hormone testing
- Treatment should be individualized and guided by a qualified clinician
*This article is for informational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before beginning any new treatment. Individual results may vary.*
References
- Islam RM, et al. Safety and efficacy of testosterone for women: a systematic review and meta-analysis of randomised controlled trial data. *Lancet Diabetes Endocrinol.* 2019 Oct. PMID 31353194. [https://pubmed.ncbi.nlm.nih.gov/31353194/](https://pubmed.ncbi.nlm.nih.gov/31353194/)
- Jayasena CN, et al. A systematic review of randomized controlled trials investigating the efficacy and safety of testosterone therapy for female sexual dysfunction in naturally menopausal women. *Clin Endocrinol (Oxf).* 2019 Mar. PMID 30488972. [https://pubmed.ncbi.nlm.nih.gov/30488972/](https://pubmed.ncbi.nlm.nih.gov/30488972/)
- Wittert GA, et al. Testosterone Treatment and Sexual Function in Men: Secondary Analysis of the T4DM Trial. *J Clin Endocrinol Metab.* 2025 Jun. PMID 39928571. [https://pubmed.ncbi.nlm.nih.gov/39928571/](https://pubmed.ncbi.nlm.nih.gov/39928571/)
Stay informed
Weekly research updates and health guides. No spam.
References
- Islam RM, et al. Safety and efficacy of testosterone for women: a systematic review and meta-analysis of randomised controlled trial data. Lancet Diabetes Endocrinol. (2019).
- Jayasena CN, et al. A systematic review of randomized controlled trials investigating the efficacy and safety of testosterone therapy for female sexual dysfunction in naturally menopausal women. Clin Endocrinol (Oxf). (2019).
- Wittert GA, et al. Testosterone Treatment and Sexual Function in Men: Secondary Analysis of the T4DM Trial. J Clin Endocrinol Metab. (2025).
Ready to get started?
Check if you qualify for a personalized treatment plan.
Check Your Eligibility →

